Company News: StrikeForce Communications, Novartis, Cegedim Dendrite and SK&A Information Services

Share this article:
Full-service medical advertising agency StrikeForce Communications landed three new assignments from eyecare firm Alcon Labs, the agency announced, adding to work for Pfizer heritage company Wyeth, Abbott Labs, Sepracor and Pozen. The independent New York agency was launched in the summer of 2009 by Mike Rutstein, formerly of Draftfcb.
 
Novartis
launched schizophrenia med Fanapt (iloperidone) in the US, the firm announced yesterday. The drug was approved last May. In October Novartis acquired US and Canadian commercialization rights to the pill from Vanda Pharmaceuticals, which retains ex-US marketing rights. A long-acting injectable (depot) formulation is being developed.
 
CRM firm Cegedim Dendrite acquired healthcare data provider SK&A Information Services for an undisclosed sum. SK&A maintains a telephone-verifiable database of contact records on over two million healthcare practitioners, including 800,000 prescribers. The database is used by biopharmaceutical companies for commercial planning and operations. Branded as SK&A, A Cegedim Company, the firm will be integrated into Cegedim Dendrite's OneKey business unit and will continue to be led by Dave Escalante, SK&A president and CEO.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.

IRS struggles with device tax

A Treasury report says the IRS is having trouble identifying who owes it money.

White House proposes Hobby Lobby alternative

A proposal by the Obama administration Friday seeks to keep contraception accessible and coverage approval at arm's length for employees of religious non-profits.